MedTrace Logo

Robot Assisted Physical Therapy for Pseudoparalysis in Massive Rotator Cuff Tear

NCT03905499 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2024-06-07

No results posted yet for this study

Summary

The primary objective of this study is to assess the efficacy of a robot assisted therapy in a clinical setting and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis. eighty patients with clinical signs of pseudoparalysis will be recruited through doctors and physical therapists based on eligibility criteria. After completing the baseline assessments, patients will be randomized into the robot-assisted physical therapy intervention or control comparison group. Enrolled patients will conduct a specific trainings program with the MJS Tecnobody (Multi Joint System 614P Tecnobody Srl, IT) three times a week over a period of six weeks. Feasibility assessment will be performed six and twelve weeks after baseline and secondary outcomes (Oxford shoulder score, subjective shoulder value, pain level during activity of daily living, active shoulder flexion and abduction and quality of life EQ-5D-5L) will be assessed at baseline, six and twelve weeks post intervention.

Conditions

  • Pseudoparalysis Due to Massive Rotator Cuff Tear

Interventions

DEVICE

Robotic assisted therapy with MJS (multi joint system) Tecnobody

The intervention will include 18 30-minutes trainings evenly distributed over a time period of 6 weeks and will be administered by the same two physiotherapists at the Schulthess clinic based on the standardized protocol

OTHER

Usual Care

Patients randomized in the usual care will receive standard of care treatment without receiving any active intervention

Sponsors & Collaborators

  • Schulthess Klinik

    lead OTHER

Principal Investigators

  • Markus Scheibel, Dr · Schulthess Klinik

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905499 on ClinicalTrials.gov